Home / Share Price Target / Star
Strides Pharma Science Share Price Target 2024, 2025, 2026 to 2039 With Charts
Strides Pharma Science Limited | |||
 | Symbol: STAR | ||
| Price: ₹1,340.05 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Strides Pharma Science Brief Company Overview
- 1.1: Strides Pharma Science Limited: A Global Pharmaceutical Powerhouse
- 1.2: Strides Pharma Science Financial Performance
- 1.2.1: Is Strides Pharma Science A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Strides Pharma Science Share Price Target For 2024
- 2.1.1: Strides Pharma Science Share Price Target Table For 2024
- 2.1.2: Summary: Strides Pharma Science Share Price Prediction For 2024
- 2.2: Strides Pharma Science Share Price Target For 2025
- 2.2.1: Strides Pharma Science Share Price Target Table For 2025
- 2.2.2: Summary: Strides Pharma Science Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Strides Pharma Science Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Strides Pharma Science Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Strides Pharma Science Past Performance
Strides Pharma Science Brief Company Overview
Strides Pharma Science Limited: A Global Pharmaceutical Powerhouse
Strides Pharma Science Limited is a leading pharmaceutical company with a global presence. Established in 1990, the company has a vast product portfolio, including pharma generics, branded generics, and anti-infective drugs. With a strong focus on research and development, Strides Pharma Science offers innovative and affordable medicines to patients worldwide.
As a renowned player in the pharmaceutical industry, the company has established strategic partnerships, such as the one with Orbicular Pharmaceutical Technologies Private Limited, to enhance its capabilities. Strides Pharma Science's commitment to quality and customer satisfaction has earned it a strong reputation among healthcare professionals and patients alike.
- Key Products and Services: Pharma generics, branded generics, anti-retrovirals, anti-malarials, anti-tuberculosis, Hepatitis drugs, and other infectious disease treatments.
- Market Presence: Africa, Australia, North America, Europe, Asia, India, and other international markets.
- Commitment: Providing affordable and accessible healthcare solutions to patients worldwide.
Advertisement
Strides Pharma Science Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 8,004.87 Crore | Market valuation of Strides Pharma Science's shares. |
| Revenue (TTM) | 3,953.45 Crore | Total revenue generated by Strides Pharma Science over the past twelve months. |
| Net Income (TTM) | -152.47 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 13.74% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -2.49% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +20% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 140.18 | Company's total debt divided by total shareholder equity. |
| Total Debt | 2,794.65 Crore | Sum of Strides Pharma Science's current & long-term financial obligations. |
| Total Cash | 326.3 Crore | Total amount of liquid funds available to Strides Pharma Science. |
| Beta | 0.77 | Beta is less than 1 indicating that the Strides Pharma Science's price is less volatile than the market. |
Is Strides Pharma Science A Good Buy For Long Term?
Based on the provided data, Strides Pharma Science's recent performance is mixed. While revenue grew by 20% over the previous quarter, the company incurred a net loss of -152.47 Crore in the last 12 months. Its debt of 2,794.65 Crore is a concern, as is the negative profit margin of -2.49%. However, the company's past returns over various periods have been positive, indicating potential for long-term growth. Overall, considering both positive and negative factors, it can be considered an "average buy" for long-term investors who are willing to accept some risk.
To predict the Strides Pharma Science's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Strides Pharma Science Share Price Target For 2024
The line chart displays the monthly closing prices of Strides Pharma Science with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Strides Pharma Science shares in 2024, see the table below.
Advertisement
Strides Pharma Science Share Price Target Table For 2024
| Strides Pharma Science's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1476.81 (+10.2%) | Price Action: Chart |
| 2024 Target 2 | 1449.27 (+8.15%) | Price Action: Chart |
| 2024 Target 1 | 1434.92 (+7.07%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 1340.05 | Strides Pharma Science's 1 share price as of Fri 30 Aug 2024 |
| Stop Loss 1 | 1302.00 (-2.84%) | Price Action: 22 Aug 2024 Low |
| Stop Loss 2 | 1288.98 (-3.82%) | Price Action: Chart |
| Stop Loss 3 | 1267.61 (-5.41%) | Price Action: Jan 2016 High |
Summary: Strides Pharma Science Share Price Prediction For 2024
In summary, Strides Pharma Science has surged by ₹690.80, achieving a notable +106.40% increase from 1st January 2024 to 30 Aug 2024. Our analysis of Strides Pharma Science for 2024 predicts an additional rise of 7.07% to 10.2% by the end of 2024 with three potential targets T1: 1434.92, T2: 1449.27, T3: 1476.81. Stop Loss at SL1: 1302.00, SL2: 1288.98, SL3: 1267.61.
Strides Pharma Science has a 52-week high of ₹1348.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹433.70, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Strides Pharma Science.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Strides Pharma Science Share Price Target For 2025
The line chart displays the monthly closing prices of Strides Pharma Science with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Strides Pharma Science shares in 2025, see the table below.
Advertisement
Strides Pharma Science Share Price Target Table For 2025
| Strides Pharma Science's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 2057.11 (+53.5%) | Fibonacci Extension Level 171.8% |
| 2025 Target 2 | 2003.57 (+49.51%) | Price Action: Chart |
| 2025 Target 1 | 1983.73 (+48.03%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1340.05 | Strides Pharma Science's 1 share price as of Fri 30 Aug 2024 |
| Stop Loss 1 | 1186.51 (-11.46%) | Price Action: Oct 2015 Low |
| Stop Loss 2 | 1166.19 (-12.98%) | Price Action: Jul 2016 High |
| Stop Loss 3 | 1146.83 (-14.42%) | Price Action: Mar 2017 High |
Summary: Strides Pharma Science Share Price Prediction For 2025
In summary, Strides Pharma Science has surged by ₹690.80, achieving a notable +106.40% increase from 1st January 2024 to 30 Aug 2024. Our analysis of Strides Pharma Science for 2025 predicts an additional rise of 48.03% to 53.5% by the end of 2025 with three potential targets T1: 1983.73, T2: 2003.57, T3: 2057.11. Stop Loss at SL1: 1186.51, SL2: 1166.19, SL3: 1146.83.
Strides Pharma Science has a All-Time high of ₹1347.55, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹433.70, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Strides Pharma Science, we have created a specific page for that check here: Strides Pharma Science Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Strides Pharma Science Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Strides Pharma Science share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 17.55% over the next 15 years.
For complete year by year Strides Pharma Science long term share price target from 2024, 2025 to 2039 check the below table.
Strides Pharma Science Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Strides Pharma Science Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,340.05 | [Current Price] |
| 2024 | ₹1,532.83 | 14.38% |
| 2025 | ₹2,390.11 | 55.92% |
| 2026 | ₹3,211.86 | 34.38% |
| 2027 | ₹4,023.31 | 25.26% |
| 2028 | ₹5,003.6 | 24.36% |
| 2029 | ₹6,145.06 | 22.81% |
| 2030 | ₹6,879.92 | 11.95% |
| 2031 | ₹7,597.61 | 10.43% |
| 2032 | ₹8,338.6 | 9.75% |
| 2033 | ₹9,422.41 | 12.99% |
| 2034 | ₹10,757.28 | 14.16% |
| 2035 | ₹11,369.73 | 5.69% |
| 2036 | ₹11,983.37 | 5.39% |
| 2037 | ₹12,653.88 | 5.59% |
| 2038 | ₹13,841.22 | 9.38% |
| 2039 | ₹14,737.09 | 6.47% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Strides Pharma Science Past Performance
- In 2000, Strides Pharma Science opening price was ₹199.57
- As of Fri 30 Aug 2024 the price stands at ₹1,340.05.
- This represents a Compound Annual Growth Rate (CAGR) of 7.91%.
- In 24 years, an investment of 10,000 would have become ₹67,146.86.
As we wrap up, we hope you like our study on Strides Pharma Science share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Strides Pharma Science Share Price History
- Strides Pharma Science Price Target Tomorrow
- Strides Pharma Science Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
